Wikipedia -WSS

Wikipedia

author：knowledge 2025-09-04 05:35:57 - browse：5

research funding, medical devices — APStock

WASHINGTON — A federal district judge on Monday granted the Biden administration’s request to dismiss a lawsuit challenging Medicare’s new drug price negotiation program from the drug industry lobbying organization PhRMA.

The move is an early but positive sign for the Biden administration in a legal fight that could stretch for years, as a host of major drugmakers, including Merck, Bristol Myers Squibb, and Johnson & Johnson, have also filed lawsuits over the constitutionality of Medicare’s new powers. The first round of drug negotiations is ongoing, and a judge heard oral arguments in a challenge brought by AstraZeneca just last month.

Newsletters

Sign up for D.C. Diagnosis

Washington never stops. Cut through the noise with our essential updates on health care politics and policy

Please enter a valid email address. Privacy Policy

The National Infusion Center Association and the Global Colon Cancer Association are also plaintiffs in PhRMA’s lawsuit. The judge dismissed the National Infusion Center Association from the case because it did not have subject matter jurisdiction to bring the lawsuit. And because NICA was the only party to the lawsuit that resides in Texas, the judge tossed out the case in its entirety.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Senate HELP committee spars over health care workforce policies

Wikipedia

focus

WSS

Teach medical students about patients with intellectual disabilities

CDC's new outbreak response network to include Northeastern

Why are Kaiser Permanente staff considering a strike?

CommonSpirit Health keeps growing, even as it loses money

Pfizer plans to depart BIO

Pfizer plans to depart BIO

focus

Wikipedia

Sign up for D.C. Diagnosis

leisure time

DIEP, the 'gold standard' of breast reconstruction, is under threat

FDA approves world's first CRISPR

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Spinal cord stimulation reduces pain in amputees, study finds

Drug repurposing or repositioning? The language matters

AstraZeneca, Daiichi breast cancer treatment succeeds in trial

New air purifier tech could be key to improving indoor air quality

Intarcia’s device

Affirmative action in medical school literally saved lives

Despite FDA approval for Lyfgenia, Bluebird faces stiff competition

explore

How Vertex's cystic fibrosis drug is changing patients' lives

Lasker Awards 2023: Winners in biomedical research

STAT Health News: mRNA flu shots, Purdue SCOTUS case, etc

Spinal cord stimulation reduces pain in amputees, study finds

Second xenotransplant done with gene

How AI helped researchers track recovery from depression

Wikipedia

focus

Wikipedia

focus